- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Radient Technologies Shares Business Development Update
Radient Technologies released an update on the development of its facility expansion, its ACMPR license and its business in Europe.
Radient Technologies (TSXV:RTI) released an update on the development of its facility expansion, its Access to Cannabis for Medical Purposes Regulations (ACMPR) license and its business in Europe.
As quoted in the press release:
Expansion of Manufacturing Capacity
Further to its previously announced expansion plans, the capacity expansion of Radient’s existing manufacturing facility is now nearing completion, with construction expected to be completed by the end of June 2018. The expansion provides a new processing line dedicated exclusively to intermediate and end-use products using extracted THC, and makes use of a number of new innovations in Radient’s proprietary extraction platform. Commissioning of the expanded facility is anticipated through the summer of 2018. As previously announced, Radient recently acquired two parcels of land adjacent to the facility, providing more than 80,000 sq. ft. of additional real estate for subsequent future capacity expansions and additions to Radient’s extraction and product development capabilities.
Cannabis Extraction Operations
Radient’s manufacturing facility (including the expansion) is located approximately 20 kilometers from the Aurora Sky facility owned by Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB:ACBFF) (Frankfurt: 21P; WKN: A1C4WM), and approximately 575 Kilometres from the site in southern Alberta where the Aurora Sun facility is being built. Aurora holds an approximately 17% ownership interest in Radient, and in November 2017, the companies entered into a Master Services Agreement (“MSA”) for the extraction of cannabinoids. Aurora has recently announced its intention to acquire MedReleaf Corp., which upon completion will create a global cannabis company with 570,000 kg per annum in funded capacity in Canada and the EU. The MedReleaf acquisition, upon completion, is expected to be accretive to Radient, as the new combination will require significant additional extraction capacity as can be delivered by Radient through its high throughput technology.
Click here to read the full press release.
Source: globenewswire.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.